Social Sentiment for AUPH
Bullish vs. Bearish opinions
Weighted Sentiment 0.00
Aurinia Pharmaceuticals Inc Forecast and Stock Analysis
Technical AUPH stock analysis for Tuesday June 25, 2019.
No changes to the price of Aurinia Pharmaceuticals Inc in the last trading day ( Tuesday, 25th Jun 2019 ). During day the stock fluctuated 2.43% from a day low at $6.18 to a day high of $6.33. The price has risen in 5 of the last 10 days and is up by 0.81% over the past 2 weeks.
- 30 day high of the AUPH stock price was $6.79 and low was $6.02.
- 90 day high was $6.90 and low was $6.00.
- 52 week high for the Aurinia Pharmaceuticals Inc - $7.85 and low - $5.06.
Aurinia Pharmaceuticals Inc lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.46% during the next 3 months and, with 90% probability hold a price between $5.82 and $6.52 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday June 20, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aurinia Pharmaceuticals Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $6.26 and $6.37. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention for the next couple of days.
Relative Strength Index (RSI)
RSI14 is 37 and the stock is currently not being overbought or oversold
Support & Resistance
Aurinia Pharmaceuticals Inc finds support from accumulated volume at $6.18.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.15 (2.43%) between high and low. For the last week, the stock has had a daily average volatility of 2.74%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
2.74 %Average volatility
Very Low Low Medium High Very High
Aurinia Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
The general sentiment holds a neutral evaluation of the stock right now. The sentiment is based upon 42 votes on StockTwits.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AUPH $6.19 ($0.00 0.00%)|
AUPH is down $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AUPH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AUPH analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us